V
76
8
GE
64
4
EQIX
59
2
AIV
40
3
ROK
48
2
KR
50
4
HP
38
4
SJM
21
2
CTAS
42
2
PG
43
2
SPG
50
4
MCO
73
5
KMX
58
6
PEG
57
2
NAVI
40
7
GM
61
4
FDX
36
3
SIG
55
3
UNP
40
2
DOW
47
3
V
76
8
GE
64
4
EQIX
59
2
AIV
40
3
ROK
48
2
KR
50
4
HP
38
4
SJM
21
2
CTAS
42
2
PG
43
2
SPG
50
4
MCO
73
5
KMX
58
6
PEG
57
2
NAVI
40
7
GM
61
4
FDX
36
3
SIG
55
3
UNP
40
2
DOW
47
3
Financhill
Back

Ascendis Pharma AS Stock Predictions

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
Sell
45

ASND
Ascendis Pharma AS

Last Price:
$138.77
Seasonality Move:
19.34%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Ascendis Pharma AS Stock Forecast

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 31.7% based on the past 9 years of stock performance.
  • Ascendis Pharma AS has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is Ascendis Pharma AS Stock Undervalued?
    The current Ascendis Pharma AS [ASND] share price is $138.79. The Score for ASND is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma AS Stock Go Up Next Year?

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 31.7% based on the past 9 years of stock performance.

Ascendis Pharma AS Stock Rating

Sell
45
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS overpriced?

  • Ascendis Pharma AS has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Ascendis Pharma AS Stock Price History

Is ASND stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com

52-Week Data

52-Week High:
161.00
52-Week Low:
111.09

Prediction Charts

Market Cap:
8.3B
Price in USD:
138.79
Volume:
72.2K
Beta:
0.65

Technical Analysis

SMA50:
130.00
SMA100:
132.55
SMA200:
135.14
52-Wk Change:
11.43%

Stock Predictions

  • Is Ascendis Pharma AS stock public?
    Yes, Ascendis Pharma AS is a publicly traded company.
  • What is the Ascendis Pharma AS stock quote today?
    The Ascendis Pharma AS stock price is 138.79 USD today.
  • How to buy Ascendis Pharma AS stock online?
    You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 130.82 132.07 132.66 129.01
Dec-6 131.33 133.00 133.95 131.18
Dec-9 132.60 132.42 133.80 127.75
Dec-10 133.49 129.67 133.49 126.74
Dec-11 130.08 134.28 134.83 127.57
Dec-12 133.98 130.64 135.71 130.17
Dec-13 129.57 129.87 131.37 128.45
Dec-16 130.13 136.60 137.65 130.00
Dec-17 136.60 140.30 141.48 136.03
Dec-18 140.35 136.02 140.70 135.02
Dec-19 136.53 137.74 139.39 134.53
Dec-20 137.00 136.24 141.37 135.61
Dec-23 137.28 139.70 140.47 135.61
Dec-24 139.70 138.79 140.22 136.34

Ascendis Pharma AS Earnings

Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma AS Forecast Revenue Growth

Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.98 per share, and an increase next year of $3.81 per share.

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.